Medical News / From ASH Meeting 2020: COVID-19 and Hematological Diseases Linked to High Mortality Rate

A study presented at the American Society of Hematology (ASH) 2020 Virtual Meeting reported that SARS-CoV-2 infection leads to increased disease severity and mortality rates in patients with hematological disorders, especially in those with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS), and active/progression status disease. The results also indicated various risk factors—such as advanced age, co-morbidities, poor performance status, low lymphocyte and platelet counts, and high LDH and CRP at admission—were associated with poorer survival prognosis. Source: MDMag. To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more

MORE MEDICAL NEWS
The modes of multiple myeloma assessment and screening has progressed over decades in near-alignment with the ... read more
A new study presented at the American Society of Hematology (ASH) 2020 Annual Meeting this weekend ... read more
A mobile health (mHealth) app may help children manage pain and symptoms related to sickle cell ... read more
Cognitive and emotional functions in pediatric patients should not be overlooked when assessing potential for sickle ... read more